Zelgen

About:

Zelgen is focused on cancer, hematology and auto-immune products.

Website: http://www.zelgen.com/en/lianxiwomen/

Top Investors: Shenzhen Capital Group, Northern Light Venture Capital, Infotech Ventures, Yingke Capital, Share Capital

Description:

Zelgen is committed itself to the innovation, R&D, manufacture and sales of new medications. The goal of Zelgen is to become one of the leading biopharmaceutical companies in China for the treatments of cancer, hematologic diseases, etc. The business strategy of Zelgen is to focus on the domestic market and to fulfill the unmet medical needs through development of high quality, safe, efficacious and affordable new medications in China.